July 27, 2017 1:11 PM ET

Pharmaceuticals

Company Overview of Rafa Laboratories Ltd.

Company Overview

Rafa Laboratories is a pharmaceutical company that develops and manufactures medicines.

5 Marpeh St.

P.O.Box: 405

Jerusalem,  91003

Israel

Founded in 1958

Phone:

972 2 589 3939

Fax:

972 2 589 3937

Key Executives for Rafa Laboratories Ltd.

General Manager
Compensation as of Fiscal Year 2017.

Rafa Laboratories Ltd. Key Developments

Therapix Biosciences Signs Non-Binding Memorandum of Understanding for Strategic Cooperation with Rafa Laboratories Ltd

Therapix Biosciences signed a non-binding memorandum of understanding for strategic cooperation with Rafa Laboratories Ltd. for the purpose of conducting a proof-of-concept clinical [trial] for a cannabinoid based product candidate to treat various medical indications characterized by lower abdominal pain. Therapix plans to make use of its licensed entourage technology for the purpose of integrating a palmitoylethanolamide (PEA) with an FDA approved cannabinoid drug. According to the MOU, which is subject to the execution of a definitive agreement within four months, Rafa will supply the approved drug to Therapix for conducting the clinical trial, and will bear the costs of, and manage the logistical and regulatory aspects related to the clinical trial, in consideration for an exclusive worldwide (excluding North America) right to manufacture the product candidate, and the right to market the product candidate in Israel.

AXIM Biotechnologies, Inc. Signs Exclusive Distribution Agreement with Rafa Pharmaceuticals

AXIM Biotechnologies, Inc. announced that it has signed an exclusive distribution agreement with Rafa Laboratories Ltd. for distribution of its award-winning cannabinoid chewing gum CanChew.® Under terms of the agreement, Rafa will submit AXIM® Biotech’s CanChew® to the Israeli Ministry of Health to be registered as a nutraceutical in the Country, and will market and distribute the product throughout Israel beginning in 2017. In addition, once AXIM® Biotech’s patented pharmaceutical chewing gum MedChew Rx™, which is currently in clinical trials for registration as a drug for patients suffering from pain and/or spasticity associated with MS, is approved by the Food and Drug Administration (FDA) and European Medicines Agency (EMA), Rafa will submit it to be registered as a Rx drug product in Israel, and will market and distribute the product throughout the Country.

Rafa Laboratories Ltd. Presents at BIO-Europe 2015, Nov-02-2015

Rafa Laboratories Ltd. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Similar Private Companies By Industry

Company Name Region
Abital Pharma Pipelines Ltd. Middle East/Africa
Active PX Ltd. Middle East/Africa
Advanced Inhalation Technology Ltd. Middle East/Africa
Angio B Ltd. Middle East/Africa
Antaki Center for Herbal Medicine Ltd. Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rafa Laboratories Ltd., please visit www.rafa.co.il. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.